Literature DB >> 10327162

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

A M Mazarati1, C G Wasterlain.   

Abstract

We examined the effects of blockers of N-methyl-D-asparate (NMDA) and +/- -alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptors on the maintenance of self-sustaining status epilepticus (SSSE) induced in rats by brief intermittent electrical stimulation of the perforant path (PPS). Blocking of NMDA receptor at the PCP site by MK-801 (0.5 mg/kg, i.p.) or ketamine (10 mg/kg, i.p.) as well as at the glycine allosteric site by intrahippocampal 5,7-dichlorokynurenic acid (5,7-DCK, 10 nmol), rapidly and irreversibly aborted both behavioral and electrographic manifestation of SSS. Intrahippocampal injection of the AMPA/kainate receptor blocker 6-cyano7-nitroquinixaline-3-dione (CNQX, 10 nmol) transiently suppressed seizures, which reappeared 4-5 h later. We suggest that the maintenance phase of SSSE depends on activation of NMDA receptors and that NMDA receptor blockers may be a promising class of compounds for the treatment of status epilepticus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327162     DOI: 10.1016/s0304-3940(99)00238-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  42 in total

1.  Modulation of hippocampal excitability and seizures by galanin.

Authors:  A M Mazarati; J G Hohmann; A Bacon; H Liu; R Sankar; R A Steiner; D Wynick; C G Wasterlain
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 3.  Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.

Authors:  Jerome Niquet; Roger Baldwin; Lucie Suchomelova; Lucille Lumley; David Naylor; Roland Eavey; Claude G Wasterlain
Journal:  Ann N Y Acad Sci       Date:  2016-07-08       Impact factor: 5.691

Review 4.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

5.  Status epilepticus: Danse Macabre in a ballet of subunits.

Authors:  Andrey Mazarati; Raman Sankar
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

6.  Recovery of network-driven glutamatergic activity in rat hippocampal neurons during chronic glutamate receptor blockade.

Authors:  Eric Leininger; Andrei B Belousov
Journal:  Brain Res       Date:  2008-11-25       Impact factor: 3.252

Review 7.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 8.  Treatment of Super-Refractory Status Epilepticus.

Authors:  Ahmad Bayrlee; Nimalya Ganeshalingam; Lisa Kurczewski; Gretchen M Brophy
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

9.  Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Authors:  A Mazarati; X Lu; S Shinmei; H Badie-Mahdavi; T Bartfai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus.

Authors:  David E Naylor; Hantao Liu; Jerome Niquet; Claude G Wasterlain
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.